Cell line producing human monoclonal antibody which binds to HTL

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving virus or bacteriophage

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435 7, 435 68, 43524027, 4351722, 436518, 436536, 436548, 436811, 436813, 935100, 935104, 935108, 935110, 424 86, 530387, 530389, 530826, 422 61, C12Q 170, G01N 3353, G01N 33577, A61K 3942

Patent

active

047228881

ABSTRACT:
The present invention is an immortalized B-cell line which produces a human monoclonal antibody IgG-Kk which specifically binds to the envelope antigen of human T-cell leukemia virus Type 1 (HTLV-I). This monoclonal antibody is useful as a diagnostic reagent by binding to the antigen specifically expressed on the surface of HTLV producing cells. Furthermore, this monoclonal antibody is useful as a therapeutic reagent, in combination with complement, for the lysis of HTLV-1 producing cells.

REFERENCES:
patent: 4588681 (1986-05-01), Sawada
Papas et al., Chemical Abstracts, 102 (1985) #198975.
Koyanagi et al., Med. Microbiol. Immunol., 173 (1984), 127-140.
Lee et al., Proc. Natl. Acad. Sci. U.S.A., 81 (1984), 3856-3860.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Cell line producing human monoclonal antibody which binds to HTL does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cell line producing human monoclonal antibody which binds to HTL, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cell line producing human monoclonal antibody which binds to HTL will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1635579

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.